Clinical

Dataset Information

0

Understanding the effects of exercise on the body’s responses to complex abdominal cancer surgery


ABSTRACT: Interventions: Patients included in this substudy will be recruited from the PRIORITY trial (Preoperative exercise for patients undergoing major abdominal cancer surgery). PRIORITY is an NHMRC-funded multicentre randomised controlled trial, investigating primarily the effects of a structured preoperative exercise program on in-hospital complications following major abdominal cancer surgery. For complete details regarding the PRIORITY trial, please see registration ACTRN12621000617864. This substudy will collect plasma biomarkers from a sample of the PRIORITY cohort, intending to recruit 144 patients for the purposes of this study. The first 144 patients recruited to PRIORITY will be invited to participate in this substudy. Biomarkers will be collected at the following timepoints: (i) within the week preceding planned surgery, and (ii) postoperatively on each day for the first 4 days following surgery. We will also screen for delirium before and after surgery and assess cognition at baseline and at 1 year following surgery. Primary outcome(s): Postoperative inflammation between intervention and control groups determined by CRP assessed using blood samples collected preoperatively and postoperatively. [ Baseline (preoperative) and for 4 postoperative days. ]

DISEASE(S): Major Abdominal Cancer Surgery,Cancer-biliary Tree (gall Bladder And Bile Duct),Surgery-other Surgery,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Cancer-ovarian And Primary Peritoneal,Cancer-oesophageal (gullet),Cancer-liver

PROVIDER: 2473378 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| EGAS00001007229 | EGA
2021-11-01 | GSE122626 | GEO
2023-12-22 | GSE221792 | GEO
2018-12-07 | GSE123413 | GEO
2018-08-22 | GSE85916 | GEO
2011-03-01 | E-MTAB-469 | biostudies-arrayexpress
2011-03-01 | E-MTAB-470 | biostudies-arrayexpress
2015-02-13 | E-MTAB-3187 | biostudies-arrayexpress
2020-07-08 | GSE153929 | GEO
2023-01-09 | GSE215937 | GEO